← All indications
Carcinoma, Ductal, Breast
An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.
Drugs by status
Phase 4 trials (1)
Phase 3 trials (3)
Phase 2 trials (6)
Phase 1 trials (2)
Other trials (1)
Organizations
Organization Involved with Phase 3 Indications (25)
- Celgene
- Amgen
- Roche
- GlaxoSmithKline
- Teva
- Vifor Inc.
- Fondazione Michelangelo
- National Cancer Institute (NCI)
- Academic and Community Cancer Research United
- Kaohsiung Medical University
- Kyoto University
- NRG Oncology
- Southwest Oncology Group
- Jiao Tong University
- National Taiwan University
- Nationale Centrum für Tumorerkrankungen
- Sun Yat-Sen University
- City of Hope National Medical Center
- Vita-Salute University of Milano. Italy
- Washington University in St. Louis
- German Breast Group Forschungs GmbH
- AGO Germany
- Government of Taiwan
- Chinese Academy of Medical Sciences
- Mackay Medical College
Organization Involved with Phase 2 Indications (16)
- AstraZeneca
- Pfizer
- G1 Therapeutics, Inc.
- West German Study Group
- Huazhong University of Science and Technology
- Jilin University
- Northwestern University
- Ohio State University
- University of South Florida
- University of Southern California
- Mayo Clinic
- University of Texas at Houston
- University of Duisburg-Essen
- Ganzhou City People's Hospital
- Assistance Publique - Hôpitaux de Paris
- Besins Healthcare
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (5)